Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% ...
Sofetabart mipitecan (Sofe-M) in combination with bevacizumab demonstrated a 79% confirmed objective response rate and 100% disease control rate, with similar activity ...
A drug at the heart of Johnson & Johnson's $3 billion takeover of Halda last year, JNJ-6143, has shown promise in an ...
In the 7MM, the total market size of HER2 NSCLC was ~USD 120 million in 2022, which is expected to increase by 2032. In 2022, the US captured a market size of ~USD 90 million, while Germany captured ...
China's top political adviser Wang Huning accompanied on Saturday Kim Jong-un, general secretary of the Workers' Party of Korea and president of the State Affairs of the Democratic People's Republic ...
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor ...
On Oct 23, China’s deputy permanent representative to the UN, Sun Lei, at a UN General Assembly Sixth Committee meeting, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results